This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Board meeting set for November 5 to approve financial results
VALIANTORG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.2 pts more than Nifty Microcap 250 and 0.8 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The board will meet on November 5, 2026 to approve the company's unaudited quarterly and half-year financial results for the period ended September 30, 2026, covering standalone and consolidated figures. Trading in company shares remains closed until November 7, 2026. No financial figures or auditor changes were disclosed.
This is only a results-calendar update. Shareholder interest will depend on the November 5 figures, which were not provided, so no performance signal can yet be confirmed.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹304.2 Cr | ₹157.3 Cr | +93.4% |
| Operating profit | ₹23.53 Cr | ₹7.16 Cr | +228.6% |
| Profit after tax | ₹17.30 Cr | ₹5.66 Cr | +205.5% |
| EBITDA margin | 12.8% | 13.4% | −0.6 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.